ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Mississippi » Internal Medicine

Top Internal Medicine Prescribers in Mississippi

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSEPH ROBERTS M.D.

Internal Medicine

52,158

$2.8M

1296
930 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

31%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $53

MUKESH JAIN MD

Internal Medicine

51,646

$2.28M

1373
988 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

35%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $53

LAURENCE DENNIS MD

Internal Medicine

39,770

$2.13M

947
625 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

34%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $53

JAMES BEASLEY M.D.

Internal Medicine

35,096

$1.7M

867
710 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $53

JAMES ROBERTS MD

Internal Medicine

34,562

$1.7M

895
642 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $53

STEVEN CLARK M.D>

Internal Medicine

34,047

$2M

828
620 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $53

HAROLD WHEELER M.D.

Internal Medicine

33,949

$1.95M

1135
641 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

45%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $53

TIMOTHY NOYES M.D.

Internal Medicine

28,929

$1.95M

832
622 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $53

MILTON HOBBS MD

Internal Medicine

27,286

$1.23M

834
748 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $53

DOROTHY GILLESPIE MD

Internal Medicine

27,179

$1.37M

580
292 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

64%
patients receiving schedule three controlled substances

Avg: 17%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $53

KEVIN HOLMES M.D.

Internal Medicine

27,156

$1.23M

709
458 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

44%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $53

ANDREA SMITH MD

Internal Medicine

26,959

$1.34M

767
501 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $53

AHMAD HAIDAR MD

Internal Medicine

26,087

$1.67M

917
703 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $53

RAMIRO MONTALVO M.D.

Internal Medicine

25,998

$1.34M

834
692 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $53

WILLUS HORNE M.D.

Internal Medicine

25,924

$1.24M

834
618 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $53

BRETT BROWN MD

Internal Medicine

25,082

$985K

867
776 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $53

LOUIS SADDLER MD

Internal Medicine

23,883

$1.36M

687
377 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

33%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $53

CHARLES HERNANDEZ DO

Internal Medicine

23,843

$1.17M

686
446 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

31%
patients receiving schedule three controlled substances

Avg: 17%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $53

MARK NORTON M.D.

Internal Medicine

23,666

$1.14M

869
652 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

30%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $53

WULF HIRSCHFIELD MD

Internal Medicine

23,117

$1.36M

1126
742 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $53

JOHN BLACK MD

Internal Medicine

22,831

$1.1M

543
352 are 65+

15%
patients receiving schedule two controlled substances

Avg: 3%

30%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $53

JOHN COX MD

Internal Medicine

22,459

$1.15M

674
508 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $53

VAISHALI SHAH MD

Internal Medicine

22,305

$893K

609
331 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$40
Average prescription price

Avg: $53

BENJAMIN SANFORD M.D.

Internal Medicine

22,133

$1.52M

840
637 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $53

DAVID GREENHAW M. D.

Internal Medicine

22,014

$1.15M

676
496 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $53

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank